ETON PHARMACEUTICALS INC. - COMMON STOCK
16.98
12-فبراير-25 16:00:18
15 متأخرة بدقائق
الأسهم
-0.29
-1.68%
نطاق اليوم
16.75 - 17.17
ISIN
N/A
المصدر
NASDAQ
-
Eton Pharmaceuticals to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021
03 أغسطس 2021 16:05:02 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Acquires U.S. and Canadian Rights to ZENEO® Hydrocortisone Autoinjector
15 يونيو 2021 16:05:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces FDA Approval of Rezipres® (Ephedrine Hydrochloride Injection)
15 يونيو 2021 10:37:52 بحسب Nasdaq GlobeNewswire
-
28 مايو 2021 08:05:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Record Revenue and Earnings
13 مايو 2021 16:05:01 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021
04 مايو 2021 16:05:01 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Appointment of Jenn Adams to its Board of Directors
17 مارس 2021 16:05:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Financial Results
16 مارس 2021 16:02:00 بحسب Nasdaq GlobeNewswire
-
04 مارس 2021 16:05:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Participate in 10th Annual SVB Leerink Global Healthcare Conference
16 فبراير 2021 16:05:00 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Sale of Neurology Portfolio
08 فبراير 2021 08:00:01 بحسب Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Acquisition of Canadian Rights for ALKINDI® SPRINKLE
14 يناير 2021 08:00:01 بحسب Nasdaq GlobeNewswire